ARTL
Price
$6.79
Change
-$0.07 (-1.02%)
Updated
Jun 27 closing price
Capitalization
3.71M
38 days until earnings call
MTNB
Price
$0.92
Change
-$0.02 (-2.13%)
Updated
Jun 27 closing price
Capitalization
4.68M
Interact to see
Advertisement

ARTL vs MTNB

Header iconARTL vs MTNB Comparison
Open Charts ARTL vs MTNBBanner chart's image
Artelo Biosciences
Price$6.79
Change-$0.07 (-1.02%)
Volume$16.7K
Capitalization3.71M
Matinas Biopharma Holdings
Price$0.92
Change-$0.02 (-2.13%)
Volume$62.25K
Capitalization4.68M
ARTL vs MTNB Comparison Chart in %
Loading...
ARTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARTL vs. MTNB commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTL is a Buy and MTNB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ARTL: $6.79 vs. MTNB: $0.92)
Brand notoriety: ARTL and MTNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTL: 171% vs. MTNB: 19%
Market capitalization -- ARTL: $3.71M vs. MTNB: $4.68M
ARTL [@Biotechnology] is valued at $3.71M. MTNB’s [@Biotechnology] market capitalization is $4.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTL’s FA Score shows that 0 FA rating(s) are green whileMTNB’s FA Score has 1 green FA rating(s).

  • ARTL’s FA Score: 0 green, 5 red.
  • MTNB’s FA Score: 1 green, 4 red.
According to our system of comparison, MTNB is a better buy in the long-term than ARTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTL’s TA Score shows that 6 TA indicator(s) are bullish while MTNB’s TA Score has 4 bullish TA indicator(s).

  • ARTL’s TA Score: 6 bullish, 4 bearish.
  • MTNB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ARTL is a better buy in the short-term than MTNB.

Price Growth

ARTL (@Biotechnology) experienced а +17.62% price change this week, while MTNB (@Biotechnology) price change was +0.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ARTL is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MTNB($4.68M) has a higher market cap than ARTL($3.71M). MTNB YTD gains are higher at: 80.412 vs. ARTL (6.761). ARTL has more cash in the bank: 12.1M vs. MTNB (6.92M). ARTL has less debt than MTNB: ARTL (95K) vs MTNB (2.71M).
ARTLMTNBARTL / MTNB
Capitalization3.71M4.68M79%
EBITDAN/A-15.35M-
Gain YTD6.76180.4128%
P/E RatioN/AN/A-
RevenueN/A0-
Total Cash12.1M6.92M175%
Total Debt95K2.71M4%
FUNDAMENTALS RATINGS
ARTL vs MTNB: Fundamental Ratings
ARTL
MTNB
OUTLOOK RATING
1..100
9586
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
4640
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
27n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MTNB's Valuation (26) in the Biotechnology industry is in the same range as ARTL (52) in the null industry. This means that MTNB’s stock grew similarly to ARTL’s over the last 12 months.

MTNB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ARTL (100) in the null industry. This means that MTNB’s stock grew similarly to ARTL’s over the last 12 months.

MTNB's SMR Rating (99) in the Biotechnology industry is in the same range as ARTL (99) in the null industry. This means that MTNB’s stock grew similarly to ARTL’s over the last 12 months.

MTNB's Price Growth Rating (40) in the Biotechnology industry is in the same range as ARTL (46) in the null industry. This means that MTNB’s stock grew similarly to ARTL’s over the last 12 months.

MTNB's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ARTL (100) in the null industry. This means that MTNB’s stock grew similarly to ARTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARTLMTNB
RSI
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 19 days ago
80%
Declines
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
ARTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CALX51.301.21
+2.42%
CALIX
XHG1.370.03
+2.24%
Xchange TEC Inc
ALLE143.891.07
+0.75%
Allegion Public Limited
EMCG12.10N/A
N/A
Embrace Change Acquisition Corp
SKYT9.89-0.56
-5.36%
SkyWater Technology

ARTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTL has been loosely correlated with MTNB. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTL jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTL
1D Price
Change %
ARTL100%
-1.08%
MTNB - ARTL
37%
Loosely correlated
-2.32%
PALI - ARTL
34%
Loosely correlated
-1.93%
APLM - ARTL
31%
Poorly correlated
+1.51%
PHIO - ARTL
28%
Poorly correlated
-1.81%
LSTA - ARTL
28%
Poorly correlated
-4.76%
More

MTNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTNB has been closely correlated with TPST. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTNB jumps, then TPST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTNB
1D Price
Change %
MTNB100%
-2.32%
TPST - MTNB
78%
Closely correlated
-2.68%
EQ - MTNB
38%
Loosely correlated
N/A
LIANY - MTNB
34%
Loosely correlated
+1.18%
INO - MTNB
31%
Poorly correlated
-6.22%
AKRO - MTNB
30%
Poorly correlated
-0.16%
More